drugset / Trial / NCT07362888
First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of the study is to determine the Maximum Tolerated Dose (MTD), the Recommended Expansion Dose and the safety and tolerability of ADCE-B05 when given as a single therapy over a range of different dose levels.
Timeline
- Start
- 2026-03-17
- Primary completion
- 2026-12-31
- Completion
- 2029-03-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADCE-B05 | Unknown | — | Intravenous |
Indications
No indication recorded.